UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

The New England journal of medicine, 2021-04, Vol.384 (16), p.1529-1541

2021

Volltextzugriff (PDF)

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Journal of clinical oncology, 2010-02, Vol.28 (5), p.780-787

2010

Volltextzugriff (PDF)

Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer

JNCI : Journal of the National Cancer Institute, 2000-04, Vol.92 (7), p.550-556

2000

Volltextzugriff (PDF)

Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4413-4421

2009

Volltextzugriff (PDF)

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation study

Investigational new drugs, 2013-12, Vol.31 (6), p.1487-1498

2013

Volltextzugriff (PDF)

Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study

Clinical cancer research, 2021-06, Vol.27 (11), p.3061-3068

2021

Volltextzugriff (PDF)

Tumor Characteristics and Clinical Outcome of Tubular and Mucinous Breast Carcinomas

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1442-1448

1999

Volltextzugriff (PDF)

Forkhead Homologue in Rhabdomyosarcoma Functions as a Bifunctional Nuclear Receptor-interacting Protein with Both Coactivator and Corepressor Functions

The Journal of biological chemistry, 2001-07, Vol.276 (30), p.27907-27912

2001

Volltextzugriff (PDF)

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

The oncologist (Dayton, Ohio), 2020-03, Vol.25 (3), p.e439-e450

2020

Volltextzugriff (PDF)

Cancer du sein chez les personnes âgées: Biologie différente et issue différente

M.S. Médecine sciences, 2007-10, Vol.23, p.29-31

Diab, Sami G.

2007

Volltextzugriff (PDF)

Breast cancer in elderly

M.S. Médecine sciences, 2007-10, Vol.23 Spec No 3, p.29

Diab, Sami G

2007

Volltextzugriff (PDF)

Abstract OT1-10-01: The Breast Cancer Index registry study: A prospective multi-center observational study to evaluate patient outcome, clinical impact, and medication adherence in HR+ breast cancer patients considering treatment with extended endocrine therapy

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-10-01-OT1-10-01

2022

Volltextzugriff (PDF)

An invitation to complete: Making advance directives part of the new patient process

Journal of clinical oncology, 2018-12, Vol.36 (34_suppl), p.7-7

2018

Volltextzugriff (PDF)

Whole transcriptome analysis comparing HR+ HER2- breast cancer tumors from patients < 50 years and >50 years

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.565-565

2021

Volltextzugriff (PDF)

Abstract PS14-11: Differential gene expression analysis and clinical utility of MammaPrint and BluePrint in male breast cancer patients

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS14-11-PS14-11

2021

Volltextzugriff (PDF)

Defining transcriptomic profiles of early-stage mucinous breast cancers: A FLEX sub study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3134-3134

2022

Volltextzugriff (PDF)

Abstract P5-07-05: Deciphering the inferior prognosis of young women with estrogen receptor-positive early-stage breast cancer through full transcriptome analysis: A FLEX database sub-study

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P5-P5-07-05

2022

Volltextzugriff (PDF)

Abstract OT2-07-01: The FLEX real-world data platform explores new gene expression profiles and investigator-initiated protocols in early-stage breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT2-07-01-OT2-07-01

2022

Volltextzugriff (PDF)

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.469-479

2018

Volltextzugriff (PDF)

Abstract CT260: The FLEX real-world data platform explores new gene expression profiles and investigator initiated protocols in early stage breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT260-CT260

2021

Volltextzugriff (PDF)

Molecular profiles of genomically high risk ER+ HER2- breast cancer tumors classified as functionally basal or luminal B by the 80-gene signature

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.563-563

2021

Volltextzugriff (PDF)

A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation

Breast cancer research and treatment, 2018-08, Vol.170 (3), p.547-557

2018

Volltextzugriff (PDF)

Abstract PS11-26: A phase 1 study of D-0502, an orally bioavailable SERD, for advanced or metastatic HR-positive and HER2-negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS11-26-PS11-26

2021

Volltextzugriff (PDF)

Abstract OT-12-01: The FLEX real-world data platform explores new gene expression profiles and investigator-initiated protocols in early stage breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-12-01-OT-12-01

2021

Volltextzugriff (PDF)

FLEX, the 30,000 breast cancer transcriptome project: A platform for early breast cancer research using full-genome arrays paired with clinical data

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS612-TPS612

2022

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(34)
Humans
(26)
Female
(21)
Oncology
(21)
Middle Aged
(17)
Aged
(16)
Adult
(15)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Chemotherapy
(10)
Male
(10)
Tumors
(10)
Aged, 80 And Over
(9)
Breast Cancer
(9)
Treatment Outcome
(9)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(8)
Antineoplastic Agents
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Breast Neoplasms - Pathology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2

Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer

Mapatumumab, an Antibody Targeting TRAIL-R1, in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Malignancies: Results of a Phase I and Pharmacokinetic Study

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies—results of a phase I dose-escalation study

Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study

Tumor Characteristics and Clinical Outcome of Tubular and Mucinous Breast Carcinomas

Forkhead Homologue in Rhabdomyosarcoma Functions as a Bifunctional Nuclear Receptor-interacting Protein with Both Coactivator and Corepressor Functions

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial

Cancer du sein chez les personnes âgées: Biologie différente et issue différente

Breast cancer in elderly

Abstract OT1-10-01: The Breast Cancer Index registry study: A prospective multi-center observational study to evaluate patient outcome, clinical impact, and medication adherence in HR+ breast cancer patients considering treatment with extended endocrine therapy

An invitation to complete: Making advance directives part of the new patient process

Whole transcriptome analysis comparing HR+ HER2- breast cancer tumors from patients < 50 years and >50 years

Abstract PS14-11: Differential gene expression analysis and clinical utility of MammaPrint and BluePrint in male breast cancer patients

Defining transcriptomic profiles of early-stage mucinous breast cancers: A FLEX sub study

Abstract P5-07-05: Deciphering the inferior prognosis of young women with estrogen receptor-positive early-stage breast cancer through full transcriptome analysis: A FLEX database sub-study

Abstract OT2-07-01: The FLEX real-world data platform explores new gene expression profiles and investigator-initiated protocols in early-stage breast cancer

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

Abstract CT260: The FLEX real-world data platform explores new gene expression profiles and investigator initiated protocols in early stage breast cancer

Molecular profiles of genomically high risk ER+ HER2- breast cancer tumors classified as functionally basal or luminal B by the 80-gene signature

A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation

Abstract PS11-26: A phase 1 study of D-0502, an orally bioavailable SERD, for advanced or metastatic HR-positive and HER2-negative breast cancer

Abstract OT-12-01: The FLEX real-world data platform explores new gene expression profiles and investigator-initiated protocols in early stage breast cancer

FLEX, the 30,000 breast cancer transcriptome project: A platform for early breast cancer research using full-genome arrays paired with clinical data

Suchergebnisse filtern